EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Comparing intralesional triamcinolone and verapamil‐triamcinolone injections in keloids: A single‐blinded randomised clinical trial

Zahra Haghani-Dogahe, Ramin Hadadi, Mojdeh Esmailzadeh, Mohammadreza Mobayen

International Wound Journal · 2023-12 · 20 (10) · 4166-4174

DOI: 10.1111/iwj.14314 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Wound Journal, online erschienen am 05.09.2023. Verfasst von Zahra Haghani-Dogahe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Burn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran. Hauptthemen laut MEDLINE: Keloid, Cicatrix, Hypertrophic. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In this clinical trial, we investigated the efficacy of two treatment methods for keloids resulting from surgical incisions: intralesional triamcinolone injections alone versus in combination with verapamil. Material and Methods Patients were divided into two groups: one received triamcinolone alone (Group T) and the other received a triamcinolone‐verapamil blend (Group VT). Regular treatments were conducted until the keloids were nearly flat or for a maximum of eight sessions.

Results

Both groups showed significant improvements, but Group VT saw quicker resolution of skin redness and needed fewer sessions. Though the Vancouver Scar Scale (VSS) scores were generally similar across both groups, Group VT exhibited greater improvements, leading to lower final scores. The VT group also attained normal scar flexibility faster than the T group.

Conclusion

These findings suggest that the combination of verapamil and triamcinolone provides a more effective treatment for keloids, thereby highlighting the potential of verapamil in scar reduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KeloidCicatrix, HypertrophicHumansVerapamilTriamcinolone AcetonideGlucocorticoidsTreatment OutcomeInjections, Intralesional

Stichwörter der Autor:innen

injectionintralesionalkeloidstriamcinoloneverapamilwoundwound healing

Substanzen

VerapamilTriamcinolone AcetonideGlucocorticoids

Autor:innen und Institutionen

  • Burn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran.
  • Department of Surgery, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran.
  • Fellowship of Burn and Reconstructive Surgeries, Burn and Regenerative Medicine Research Center, Guilan University of Medical Sciences, Rasht, Iran.

Zitieren

APA

Haghani-Dogahe, Z., Hadadi, R., Esmailzadeh, M., & Mobayen, M. (2023). Comparing intralesional triamcinolone and verapamil‐triamcinolone injections in keloids: A single‐blinded randomised clinical trial. International Wound Journal, 20(10), 4166-4174. https://doi.org/10.1111/iwj.14314

Vancouver

Haghani-Dogahe Z, Hadadi R, Esmailzadeh M, Mobayen M. Comparing intralesional triamcinolone and verapamil‐triamcinolone injections in keloids: A single‐blinded randomised clinical trial. International Wound Journal. 2023;20(10):4166-4174. doi:10.1111/iwj.14314

BibTeX
@article{HaghaniDogahe2023,
  author = {Haghani-Dogahe, Zahra and Hadadi, Ramin and Esmailzadeh, Mojdeh and Mobayen, Mohammadreza},
  title = {Comparing intralesional triamcinolone and verapamil‐triamcinolone injections in keloids: A single‐blinded randomised clinical trial},
  journal = {International Wound Journal},
  year = {2023},
  volume = {20},
  number = {10},
  pages = {4166--4174},
  doi = {10.1111/iwj.14314}
}
Kostenlos starten →